#1 Clinical Trials Search in Europe

POTASSIUM HYDROXIDE

Potassium hydroxide (KOH) is being investigated as a potential treatment for molluscum contagiosum, a common viral skin infection primarily affecting children. A clinical trial has been designed to evaluate the efficacy and tolerance of different concentrations of potassium hydroxide when applied topically to molluscum lesions. This research aims to provide healthcare providers with evidence-based options for treating this contagious condition in primary care settings, potentially offering patients a more accessible treatment alternative. The study compares 10% and 15% KOH solutions against a placebo to determine healing rates and assess side effects over a 60-day period.

Table of Contents

What is Potassium Hydroxide?

Potassium hydroxide (KOH) is a chemical compound that is being studied as a topical treatment for certain skin conditions. In medical settings, it can be prepared as an aqueous solution (mixed with water) at different concentrations, such as 10% and 15%, for topical application on the skin[1]. This compound is sometimes used in dermatology because of its ability to break down certain types of tissue.

Understanding Molluscum Contagiosum

Molluscum contagiosum is a viral skin infection that primarily affects children. As indicated by its name, it is highly contagious and can spread through direct skin contact or by touching contaminated objects[1]. The infection causes small, raised bumps or lesions on the skin that may be flesh-colored, white, or pink.

While molluscum contagiosum is not a serious medical condition and often clears up on its own eventually, treatment may be recommended because:

  • The infection is highly contagious and can spread to other parts of the body or to other people
  • The visible lesions may cause aesthetic concerns
  • Some children may experience psychological distress due to the appearance of the bumps

How Potassium Hydroxide Treats Molluscum Contagiosum

Potassium hydroxide works as a caustic agent when applied to the skin. This means it gradually breaks down the tissue of the molluscum lesions[1]. By causing mild controlled damage to the affected area, it helps the body clear the viral infection. The treatment is aimed at the complete disappearance of lesions in the affected zones.

Clinical Research on Potassium Hydroxide

A double-blind, randomized clinical trial has been designed to test the effectiveness and tolerance of potassium hydroxide for treating molluscum contagiosum[1]. The study compares three treatment groups:

  1. 10% potassium hydroxide aqueous solution
  2. 15% potassium hydroxide aqueous solution
  3. Placebo (saline solution)

This research approach helps determine whether potassium hydroxide is truly effective compared to no treatment (placebo) and which concentration (10% or 15%) might offer the best balance of effectiveness and tolerability[1].

How to Apply Potassium Hydroxide

In the clinical trial, the treatment consists of daily topical application of the potassium hydroxide solution to the affected areas[1]. The medication is applied directly to the molluscum lesions, not to surrounding healthy skin. Always follow your healthcare provider’s specific instructions on how to apply this treatment, as improper application could cause skin damage.

Possible Side Effects

As part of the clinical research, several potential side effects of potassium hydroxide treatment are being monitored[1], including:

  • Hyperpigmentation: darkening of the skin at the treatment site
  • Itching: an uncomfortable sensation that may cause a desire to scratch
  • Burning sensation: a feeling of heat or burning at the application site
  • Pain: discomfort at the site where the solution is applied

These side effects are being carefully evaluated to determine the overall tolerance of different concentrations of potassium hydroxide[1].

Treatment Effectiveness and Follow-up

The main goal of potassium hydroxide treatment is the complete healing of molluscum contagiosum, defined as the disappearance of lesions in the affected areas[1]. To properly evaluate this effectiveness, the clinical trial includes several follow-up visits at 15, 30, 45, and 60 days after starting treatment.

During these follow-up visits, healthcare providers assess[1]:

  • The surface area affected by the condition
  • The number of lesions
  • The size of individual lesions
  • The density of lesions in affected areas
  • Any recurrence of previously healed lesions

The natural progression of untreated molluscum contagiosum is also being studied in the placebo group to better understand how the infection evolves without intervention[1].

Study Aspect Details
Clinical Trial Title Efficacy and Tolerance of the Topical Application of Potassium Hydroxide (10% and 15%) in the Treatment of Molluscum Contagiosum
Condition Studied Molluscum Contagiosum (a viral skin infection common in children)
Treatment Groups 1. 10% Potassium Hydroxide aqueous solution
2. 15% Potassium Hydroxide aqueous solution
3. Placebo (saline solution)
Application Method Daily topical application to affected areas
Study Duration 60 days with follow-up visits at 15, 30, 45, and 60 days
Primary Outcome Disappearance of molluscum lesions
Secondary Outcomes – Changes in affected zone characteristics (surface, number of lesions, size, density)
– Treatment tolerance (hyperpigmentation, itching, burning, pain)
– Recurrence rate
– Natural evolution of untreated lesions
Study Design Double-blind, randomized clinical trial

FAQ

  • What is molluscum contagiosum? Molluscum contagiosum is a non-serious viral skin infection commonly seen in children. It causes small, raised bumps or lesions on the skin. As indicated by its name, it is highly contagious and can spread through direct contact with infected skin or contaminated objects.
  • How is potassium hydroxide (KOH) being used in this clinical trial? In this clinical trial, potassium hydroxide is being tested as a topical treatment applied directly to molluscum contagiosum lesions. The study compares two different concentrations of KOH in aqueous solution (10% and 15%) against a placebo (saline solution) to determine which is most effective and well-tolerated.
  • How long does the treatment and follow-up last in this trial? The treatment involves daily application of either 10% KOH solution, 15% KOH solution, or placebo. Participants are followed for 60 days with scheduled check-ups at 15, 30, 45, and 60 days to monitor progress and evaluate how well the treatment is working.
  • What outcomes are researchers measuring in this clinical trial? The primary outcome researchers are measuring is efficacy, defined as the complete disappearance of molluscum lesions. Secondary outcomes include tracking changes in the affected areas (surface area, number of lesions, size, and density), evaluating tolerance (side effects like hyperpigmentation, itching, burning, and pain), measuring recurrence rates, and observing the natural progression of untreated lesions in the control group.
  • Why is this research important for patients with molluscum contagiosum? This research is important because molluscum contagiosum, while not serious, can cause aesthetic concerns and psychological distress. It is also highly contagious, making effective treatments valuable. If potassium hydroxide proves to be effective and well-tolerated, it could provide primary care physicians with an accessible, non-invasive treatment option that can be easily administered in standard healthcare settings.

Ongoing Clinical Trials on POTASSIUM HYDROXIDE

  • Study on the Effectiveness of 5% Potassium Hydroxide Solution for Treating Mild to Moderate Actinic Keratosis in Adults

    Recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Germany

  • Study of Intradialytic Parenteral Nutrition for Muscle Protein Production in Patients on Long-term Hemodialysis Treatment

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

Glossary

  • Molluscum contagiosum: A viral skin infection that causes small raised bumps or lesions on the skin's surface. It's common in children and spreads through direct contact with infected skin or contaminated objects.
  • Potassium hydroxide (KOH): A chemical compound being tested as a topical treatment for molluscum contagiosum. In this trial, it's being applied in 10% and 15% aqueous solutions.
  • Topical application: A method of applying medication directly to the skin surface rather than taking it orally or by injection.
  • Placebo: An inactive substance (in this case, saline solution) given to the control group that has no therapeutic effect, used as a comparison to measure the effectiveness of the active treatment.
  • Double-blind: A research design where neither the participants nor the researchers know which treatment each participant is receiving, helping to prevent bias in the study results.
  • Randomized clinical trial: A study where participants are randomly assigned to different treatment groups to compare outcomes, considered the gold standard for testing new treatments.
  • Efficacy: How well a treatment works under ideal circumstances. In this study, efficacy is measured by the complete disappearance of molluscum lesions.
  • Tolerance: How well a patient can endure side effects of a treatment. In this study, tolerance is evaluated by monitoring for hyperpigmentation, itching, burning, and pain.
  • Hyperpigmentation: Darkening of an area of skin caused by increased melanin production, which can occur as a side effect of some skin treatments.
  • Recurrence rate: The frequency at which a condition returns after initial treatment has cleared it.
  • Control group: The group of participants in a study who receive a placebo rather than the treatment being tested, used as a baseline for comparison.
  • Aqueous solution: A solution where water is the solvent, in this case used to dissolve the potassium hydroxide for application.
  • KOH: The chemical abbreviation for potassium hydroxide.

References

  1. https://clinicaltrials.gov/study/NCT01348386